Search research articles
Contact Us
Filters
Showing results (1-10 of 170) with videos related to
Page
of 17
Sort By:
Annals of Surgical Oncology
|
May 1, 2019
Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence, Technically Feasible but Influence on Oncologic Outcomes Yet to be Completely Defined
James W Jakub
Annals of Surgical Oncology
|
February 25, 2016
The Search Continues for the Ideal Method to Localize Nonpalpable Breast Lesions
James W Jakub
Annals of Surgical Oncology
|
April 9, 2024
Localization Devices and the Surgeon Innovator
James W Jakub
American Journal of Surgery
|
April 7, 2009
False negative rate for frozen section analysis of SLNs
James W Jakub
American Journal of Surgery
|
July 2, 2019
The achilles heel of minimally invasive inguinal lymph node dissection: Seroma formation
Nicolas Contreras, James W Jakub
Journal of Surgical Oncology
|
June 20, 2017
Response to HER2 status might be independent determinant associated with no residual disease at surgical resection in patients with DCIS
Brittany L Murphy, James W Jakub
The Journal of Surgical Research
|
December 7, 2020
Anterior Axillary Arch: An Anatomic Variant Every Surgeon Operating in the Axilla Should Be Aware of
Jennifer A Yonkus, James W Jakub
Annals of Surgical Oncology
|
May 2, 2022
ASO Author Reflections: Minimally Invasive Inguinal Lymphadenectomy, an Incremental Step in the Evolution of the Management of Advanced Melanoma
James W Jakub, Mark B Faries
The American Surgeon
|
May 16, 2002
Re: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Charles E Cox, James W Jakub
Annals of Surgical Oncology
|
July 21, 2023
ASO Author Reflections: Axillary Reverse Mapping: Where Do We Go from Here?
Molly M Benolken, James W Jakub
Page
of 17
Search research articles
Search
Showing results (1-10 of 170) with videos related to
Sort By:
Page
of 17
Annals of Surgical Oncology
|
May 1, 2019
Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence, Technically Feasible but Influence on Oncologic Outcomes Yet to be Completely Defined
James W Jakub
Annals of Surgical Oncology
|
February 25, 2016
The Search Continues for the Ideal Method to Localize Nonpalpable Breast Lesions
James W Jakub
Annals of Surgical Oncology
|
April 9, 2024
Localization Devices and the Surgeon Innovator
James W Jakub
American Journal of Surgery
|
April 7, 2009
False negative rate for frozen section analysis of SLNs
James W Jakub
American Journal of Surgery
|
July 2, 2019
The achilles heel of minimally invasive inguinal lymph node dissection: Seroma formation
Nicolas Contreras, James W Jakub
Journal of Surgical Oncology
|
June 20, 2017
Response to HER2 status might be independent determinant associated with no residual disease at surgical resection in patients with DCIS
Brittany L Murphy, James W Jakub
The Journal of Surgical Research
|
December 7, 2020
Anterior Axillary Arch: An Anatomic Variant Every Surgeon Operating in the Axilla Should Be Aware of
Jennifer A Yonkus, James W Jakub
Annals of Surgical Oncology
|
May 2, 2022
ASO Author Reflections: Minimally Invasive Inguinal Lymphadenectomy, an Incremental Step in the Evolution of the Management of Advanced Melanoma
James W Jakub, Mark B Faries
The American Surgeon
|
May 16, 2002
Re: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Charles E Cox, James W Jakub
Annals of Surgical Oncology
|
July 21, 2023
ASO Author Reflections: Axillary Reverse Mapping: Where Do We Go from Here?
Molly M Benolken, James W Jakub
Page
of 17